These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 28199985)

  • 21. Higher expression of the androgen-regulated gene PSA/HK3 mRNA in prostate cancer tissues predicts biochemical recurrence-free survival.
    Sterbis JR; Gao C; Furusato B; Chen Y; Shaheduzzaman S; Ravindranath L; Osborn DJ; Rosner IL; Dobi A; McLeod DG; Sesterhenn IA; Srivastava S; Cullen J; Petrovics G
    Clin Cancer Res; 2008 Feb; 14(3):758-63. PubMed ID: 18245536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Androgen-independent LNCaP cells are a subline of LNCaP cells with a more aggressive phenotype and androgen suppresses their growth by inducing cell cycle arrest at the G1 phase.
    Yu P; Duan X; Cheng Y; Liu C; Chen Y; Liu W; Yin B; Wang X; Tao Z
    Int J Mol Med; 2017 Nov; 40(5):1426-1434. PubMed ID: 28901378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The chromatin remodeling factor SRCAP modulates expression of prostate specific antigen and cellular proliferation in prostate cancer cells.
    Slupianek A; Yerrum S; Safadi FF; Monroy MA
    J Cell Physiol; 2010 Aug; 224(2):369-75. PubMed ID: 20432434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of naturally occurring and synthetic organoselenium compounds on biomarkers in androgen responsive and androgen independent human prostate carcinoma cells.
    Pinto JT; Sinha R; Papp K; Facompre ND; Desai D; El-Bayoumy K
    Int J Cancer; 2007 Apr; 120(7):1410-7. PubMed ID: 17205524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prosaposin is a novel androgen-regulated gene in prostate cancer cell line LNCaP.
    Koochekpour S; Lee TJ; Wang R; Sun Y; Delorme N; Hiraiwa M; Grabowski GA; Culig Z; Minokadeh A
    J Cell Biochem; 2007 Jun; 101(3):631-41. PubMed ID: 17171640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of hepatocyte nuclear factor-3 alpha (Forkhead Box A1) and androgen receptor in transcriptional regulation of prostatic genes.
    Gao N; Zhang J; Rao MA; Case TC; Mirosevich J; Wang Y; Jin R; Gupta A; Rennie PS; Matusik RJ
    Mol Endocrinol; 2003 Aug; 17(8):1484-507. PubMed ID: 12750453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter.
    Cleutjens KB; van der Korput HA; van Eekelen CC; van Rooij HC; Faber PW; Trapman J
    Mol Endocrinol; 1997 Feb; 11(2):148-61. PubMed ID: 9013762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p66Shc protein through a redox mechanism enhances the progression of prostate cancer cells towards castration-resistance.
    Miller DR; Ingersoll MA; Chatterjee A; Baker B; Shrishrimal S; Kosmacek EA; Zhu Y; Cheng PW; Oberley-Deegan RE; Lin MF
    Free Radic Biol Med; 2019 Aug; 139():24-34. PubMed ID: 31100478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Androgen-dependent gene expression of prostate-specific antigen is enhanced synergistically by hypoxia in human prostate cancer cells.
    Horii K; Suzuki Y; Kondo Y; Akimoto M; Nishimura T; Yamabe Y; Sakaue M; Sano T; Kitagawa T; Himeno S; Imura N; Hara S
    Mol Cancer Res; 2007 Apr; 5(4):383-91. PubMed ID: 17426252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Androgen receptor-mediated repression of novel target genes.
    Prescott J; Jariwala U; Jia L; Cogan JP; Barski A; Pregizer S; Shen HC; Arasheben A; Neilson JJ; Frenkel B; Coetzee GA
    Prostate; 2007 Sep; 67(13):1371-83. PubMed ID: 17624924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation.
    Hsieh CL; Fei T; Chen Y; Li T; Gao Y; Wang X; Sun T; Sweeney CJ; Lee GS; Chen S; Balk SP; Liu XS; Brown M; Kantoff PW
    Proc Natl Acad Sci U S A; 2014 May; 111(20):7319-24. PubMed ID: 24778216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-4 in patients with prostate cancer.
    Takeshi U; Sadar MD; Suzuki H; Akakura K; Sakamoto S; Shimbo M; Suyama T; Imamoto T; Komiya A; Yukio N; Ichikawa T
    Anticancer Res; 2005; 25(6C):4595-8. PubMed ID: 16334148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indole-3-carbinol inhibition of androgen receptor expression and downregulation of androgen responsiveness in human prostate cancer cells.
    Hsu JC; Zhang J; Dev A; Wing A; Bjeldanes LF; Firestone GL
    Carcinogenesis; 2005 Nov; 26(11):1896-904. PubMed ID: 15958518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of novel androgen receptor target genes in prostate cancer.
    Jariwala U; Prescott J; Jia L; Barski A; Pregizer S; Cogan JP; Arasheben A; Tilley WD; Scher HI; Gerald WL; Buchanan G; Coetzee GA; Frenkel B
    Mol Cancer; 2007 Jun; 6():39. PubMed ID: 17553165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The atypical GATA protein TRPS1 represses androgen-induced prostate-specific antigen expression in LNCaP prostate cancer cells.
    van den Bemd GJ; Jhamai M; Brinkmann AO; Chang GT
    Biochem Biophys Res Commun; 2003 Dec; 312(3):578-84. PubMed ID: 14680804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.
    Culig Z; Hobisch A; Cronauer MV; Radmayr C; Trapman J; Hittmair A; Bartsch G; Klocker H
    Cancer Res; 1994 Oct; 54(20):5474-8. PubMed ID: 7522959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcription factor FoxM1 is the downstream target of c-Myc and contributes to the development of prostate cancer.
    Pan H; Zhu Y; Wei W; Shao S; Rui X
    World J Surg Oncol; 2018 Mar; 16(1):59. PubMed ID: 29554906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LINE-1 ORF-1p functions as a novel androgen receptor co-activator and promotes the growth of human prostatic carcinoma cells.
    Lu Y; Feng F; Yang Y; Gao X; Cui J; Zhang C; Zhang F; Xu Z; Qv J; Wang C; Zeng Z; Zhu Y; Yang Y
    Cell Signal; 2013 Feb; 25(2):479-89. PubMed ID: 23153584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Androgen receptor remains critical for cell-cycle progression in androgen-independent CWR22 prostate cancer cells.
    Yuan X; Li T; Wang H; Zhang T; Barua M; Borgesi RA; Bubley GJ; Lu ML; Balk SP
    Am J Pathol; 2006 Aug; 169(2):682-96. PubMed ID: 16877366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
    Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
    J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.